Request FREE sample PDF
Pharmacy benefit management market
Microfluidic Chips Market Report Overview
The global microfluidic chips market size is USD 4923.8 million in 2022 and is projected to touch USD 11705.4 million by 2031, exhibiting a CAGR of 10.1% during the forecast period.
Microfluidic chips, also known as lab-on-a-chip devices, are miniaturised platforms that integrate numerous laboratory operations and components onto a single chip-scale device. These chips manipulate small amounts of fluids, often in the microliter or nanoliter range, within tiny channels and chambers. They have acquired substantial attention and appeal in recent years as a result of their diverse uses in domains such as biology, chemistry, medicine, and biotechnology. The chips are devices that control the flow of fluids through small channels. They are utilized in a range of applications, including medicine administration, diagnostics, and environmental monitoring. The chips are essential because they enable for fine fluid control at the microscale. This allows researchers to conduct sophisticated experiments and studies that would be difficult or impossible to carry out on a bigger scale.
COVID-19 Impact: The COVID-19 Underlying Condition Uplifted the Market Growth
The global COVID-19 pandemic has been unprecedented and staggering, with the microfluidic chips market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributed to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The COVID-19 epidemic had a substantial influence on the patient monitoring device market. Because of the increasing number of COVID-19 cases that require continuous patient monitoring, the demand for patient monitoring equipment has increased significantly during the COVID-19 pandemic. Moreover, during the COVID-19 epidemic, industries expanded their production of crucial or necessary medical ailments. COVID-19 has had and will continue to have a diverging impact on microfluidic chips market share. It also claimed that in fiscal year 2022, there will be a continued acceptance and expansion in patient treatments. As a result, the COVID-19 pandemic had a good impact on the microfluidic chips market growth, and the market is increasing rapidly and is expected to continue to rise during the forecast period.
LATEST TRENDS
"The Growing Number of Research and Development Activities to Attract the Market Share"
The increased R&D activities for creating innovative microfluidic chips for medication delivery applications are related to the growth. The increasing number of R&D activities in the life sciences sector is expected to drive demand for the chips in the projected time-frame. The chips have transformed a wide range of scientific and technological disciplines by offering new experimental and analytical capabilities. Their continuous development and implementation have the potential to advance future research, diagnostics, and healthcare. During the projection period, such measures are expected to drive the microfluidic chips market demand.
Microfluidic Chips Market Segmentation
- By Type
Based on type the microfluidic chips market is classified into polymers, ceramics, semi, conductors and others.
The polymers are the leading part of the type segment in the market.
- By Application
Based on application the microfluidic chips market is classified as pharmaceutical, diagnostic, drug deliver and others"."
The part pharmaceutical is the leading application in the market.
DRIVING FACTORS
"Increasing Demand of Miniaturization and Fluid Manipulation to Enhance the Market Growth"
The growing demand for miniaturization in the electronics industry is projected to propel the microfluidic chip market forward. The chips allow standard laboratory operations to be downsized onto a chip-scale platform. To produce intricate channel architectures and functional components, they frequently use techniques such as photolithography, soft lithography, or micro-electromechanical systems (MEMS). The chips enable for fine fluid control and manipulation. They are capable of transporting, mixing, separating, and analyzing small amounts of liquids, as well as performing other fluidic processes such as pumping, valving, and metering. Due to effects such as laminar flow and surface tension, the behavior of fluids in microfluidic channels can differ dramatically from that of macroscale systems.
"Rapid Growth with Enormous Applications in Laboratory and Biomedical Field Reinforce the Market Growth"
Microfluidic chips outperform traditional laboratory techniques in various ways. They require minimal sample volumes, which reduces the use of expensive reagents. Miniaturization allows for more rapid analysis and reactions, as well as high-throughput screening. Furthermore, integrating several components on a single chip improves automation, decreases manual handling, and improves experimental repeatability. Microfluidic chips have a wide range of biomedical uses. They are utilized in a variety of applications, including point-of-care diagnostics, drug discovery, genomics, proteomics, cell analysis, tissue engineering, and personalized medicine. These chips can be used for high-throughput drug screening, fast diagnostic assays, or studying cellular behavior in controlled micro environments.
RESTRAINING FACTORS
"Certain challenges with fabrication and High Initial Investment Cost to Hamper the Market Growth"
Despite their enormous promise, microfluidic chips face several problems. Fabrication and design of sophisticated microfluidic systems can be technically hard and necessitate specialized knowledge. It might be difficult to provide dependable and continuous fluid flow, minimize clogging, and integrate appropriate materials for biological applications. Furthermore, the transition of microfluidic technology from research facilities to commercial applications frequently necessitates addressing concerns of scalability, production, and cost-effectiveness. Furthermore, the high initial investment prices and lack of technical skills are limiting this market's growth to some extent.
Microfluidic Chips Market Regional Insights
"North American Region to Rule Out with Advanced Healthcare Facilities and High Research and Development "
North America dominates the microfluidics market and is expected to hold the majority of the market during the forecast period due to factors such as the region's well-established healthcare system and higher adoption of novel therapeutics among the general population, as well as the region's increasing prevalence of infectious and chronic diseases. The area is likely to maintain its position during the projection period due to significant research and development operations done by major pharmaceutical and biotechnology businesses in order to commercialise goods at a lesser cost. Furthermore, growing R&D spending by various government agencies in this region is one of the primary elements driving regional growth.
KEY INDUSTRY PLAYERS
"Prominent Manufacturers to Contribute Towards Expansion of Market"
The report is an extensive research which presents the historic and futuristic performance of industry with competitive landscape analysis which incorporates prominent key players, and revenue trends of industry. The data combines recent technology advancements, trends, manufacturing line mergers and acquisitions, market research, and other elements.
List of Market Players Profiled
- Agilent (U.S.A)
- Fluidigm Corporation (U.S.A)
- Micralyne, Inc (Canada)
- Becton Dickinson (U.S.A)
- Danaher (U.S.A)
- PerkinElmer (U.S.A)
- Bio-Rad Laboratories (U.S.A)
- Dolomite (U.K)
- 908 Devices (U.S.A)
- MicroLIQUID (Spain)
- MicruX Technologies (Spain)
- Micronit (The Netherlands)
- Fluigent (France).
REPORT COVERAGE
The report anticipates a detailed analysis of the global market size at the regional and national level, the segmentation market growth and market share. The prime objective of the report is to help user understand the market in terms of definition, market potential, influencing trends, and the challenges faced by the market. Analysis of sales, the impact of the market players, recent developments, opportunity analysis, strategic market growth analysis, territorial market expansion, and technological innovations are the subject matter explained in the report.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 4923.8 Million in 2022 |
Market Size Value By |
US$ 11705.4 Million by 2031 |
Growth Rate |
CAGR of 10.1% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the Microfluidic Chips market expected to touch by 2031?
The global microfluidic chips market is expected to reach USD 11705.4 million by 2031.
-
What CAGR is the Microfluidic Chips market expected to exhibit by 2031?
The Microfluidic Chips market is expected to exhibit a CAGR of 27.8% by 2031.
-
Which are the driving factors of the Microfluidic Chips market?
Increasing demand from miniaturization and fluid manipulation and rapid growth with enormous applications in laboratory and biomedical field are the driving factors of the Microfluidic Chips market.
-
Which are the top companies operating in the Microfluidic Chips market?
Agilent, Fluidigm Corporation, Micralyne, Inc, Becton Dickinson, Danaher, PerkinElmer, Bio-Rad Laboratories, Dolomite, 908 Devices, MicroLIQUID, MicruX Technologies, Micronit, Fluigent and others are the top companies operating in the Microfluidic Chips market.